Akebia Therapeutics Inc. sell Global_Player
Start price
23.05.23
/
50%
€1.44
Target price
23.05.24
-
Performance (%)
-21.56%
End price
25.05.23
€1.13
Summary
This prediction ended on 25.05.23 with a price of €1.13. The price of Akebia Therapeutics Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -21.56%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 3.336% | 3.336% | -24.405% |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % |
According to Global_Player what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Sell Akebia Therapeutics Inc.